查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
核酸治疗 CDMO 市场，按产品类型、服务、按应用、最终用户、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1408890

核酸治疗 CDMO 市场，按产品类型、服务、按应用、最终用户、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Nucleic Acid Therapeutics CDMO Market, By Product Type, By Service, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年核酸治疗 CDMO 市场规模为 117.563 亿美元，2023 年至 2030 年复合CAGR为 10.3%。

核酸治疗CDMO市场-市场动态

核酸疗法的进步、复杂的製造程序以及增加的投资来推动市场需求

该市场主要受到核酸疗法的进步、复杂的製造程序和增加的投资的引导。此外，监管部门对核酸疗法的批准不断增加，以及全球对个人化医疗需求的成长，将推动对具有成本效益的 CDMO 服务的需求，从而推动市场扩张。核酸治疗根据个人的基因组成提供个人化的医疗保健。随着对精准医疗和标靶治疗的需求不断增加，这些CDMO 成为製药和生物最终用户公司的重要合作伙伴，旨在发挥核酸药物的潜力。他们致力于维护严格的品质标准，克服监管复杂性，并采用最先进的技术促进了这些复杂分子的高效和可规模化生产。因此，这推动了基于核酸的变革疗法的进步和可及性，满足了广泛的医疗需求。

核酸治疗 CDMO 市场 - 关键见解

  • 根据我们的研究分析师分享的分析，预计全球市场在预测期内（2023-2030 年）每年将以 10.3% 左右的CAGR成长
  • 根据产品类型细分，预计基于 RNA 的疗法将在 2022 年显示最大的市场份额
  • 从服务细分来看，2022年製造业服务业为主导类型
  • 从应用细分来看，肿瘤学是2022年的主导类型
  • 按地区划分，北美是 2022 年的主要收入来源

核酸治疗 CDMO 市场-細項分析：

  • 全球核酸治疗 CDMO 市场根据产品类型、服务、应用、最终用户和地区进行细分。
  • 根据产品类型，市场分为两类：基因疗法和基于RNA的疗法。 2022年，以RNA为基础的疗法领域成为全球市场的主导力量。 ClinicalTrials.gov资料显示，超过 3,500 项正在进行的临床试验涉及针对不同疾病的 RNA 疗法。最近试验的令人鼓舞的结果强调了基于 RNA 的药物在治疗各种疾病方面的巨大潜力，预计将推动这一领域的成长。
  • 市场根据服务分为四类：製程开发和最佳化、製造服务、分析和品质控制服务及其他。到 2022 年，製造服务类别将占据重要的收入份额。基于核酸的疗法（包括 RNA 和基因疗法）需要製造方面的专业知识和专业知识。专门专注于核酸製造的 CDMO 对这些疗法有了深入的了解，从而赋予了它们竞争优势。在核酸治疗 CDMO 市场中，服务进一步细分为製程开发和优化、製造服务、分析和品质控制服务等。

核酸治疗 CDMO 市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区以及中东和非洲地区。这些区域根据开展业务的国家进一步划分。

核酸治疗CDMO市场-竞争格局：

在核酸合约开发和製造组织 (CDMO) 的动态领域内，公司透过采用多方面的方法来策略性地引导产业。这些实体透过重点关注 mRNA、siRNA、基因编辑或寡核苷酸合成片段来优先考虑专业化。透过完善这些专业领域的专业知识，CDMO 可以根据客户的具体要求提供客製化解决方案和优化服务。同时，他们强调对最先进的最终用户和基础设施进行大量投资，确保他们的设施配备了核酸製造流程的最新进展。合规性仍然是其运营的一个基本方面，并严格关注满足和超过 FDA 或 EMA 等机构制定的监管标准。此外，他们的服务强调灵活性和可扩展性，从而实现适应性强的製造解决方案，以适应不同的项目规模和规格。这种适应性有助于灵活地响应製药和生物最终用户合作伙伴不断变化的需求，从而巩固他们在竞争市场中的地位。

最近的发展：

2023 年 4 月，Exothera 与 Quantoom Biosciences 合作，利用 Quantoom 的创新 Nfinity 最终用户－专为 RNA 打造的尖端连续生产平台。这项合作关係使 Exothera 成为全球领先的合约开发和製造组织 (CDMO)，为连续 RNA 生产提供现成的服务，扩大其在 RNA 製造领域的专业知识。

目录

第 1 章：核酸治疗 CDMO 市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的核酸治疗 CDMO 市场片段
    • 核酸治疗 CDMO 市场片段（依服务）
    • 核酸治疗 CDMO 市场片段（依应用）
    • 最终用户的核酸治疗 CDMO 市场片段
    • 按国家/地区分類的核酸治疗 CDMO 市场片段
    • 按地区分類的核酸治疗 CDMO 市场片段
  • 竞争洞察

第 3 章：核酸治疗 CDMO 主要市场趋势

  • 核酸治疗 CDMO 市场驱动因素
    • 市场驱动因素的影响分析
  • 核酸治疗 CDMO 市场限制
    • 市场限制影响分析
  • 核酸治疗 CDMO 市场机会
  • 核酸治疗CDMO市场未来趋势

第 4 章：核酸治疗 CDMO 产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：核酸治疗 CDMO 市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：核酸治疗 CDMO 市场格局

  • 2022 年核酸治疗 CDMO 市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：核酸治疗 CDMO 市场 - 依产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 基因治疗
    • 基于RNA的疗法

第 8 章：核酸治疗 CDMO 市场 - 按服务

  • 概述
    • 按服务分類的细分市场占有率分析
    • 製程开发与最佳化
    • 製造服务
    • 分析和品质控制服务
    • 其他的

第 9 章：核酸治疗 CDMO 市场 -按应用

  • 概述
    • 按应用的细分市场占有率分析
    • 肿瘤学
    • 遗传性疾病
    • 传染性疾病
    • 其他的

第 10 章：核酸治疗 CDMO 市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 製药公司
    • 政府及学术研究机构
    • 生技公司

第 11 章：核酸治疗 CDMO 市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美核酸治疗CDMO主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按服务）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲核酸治疗CDMO主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按服务）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区核酸治疗CDMO主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模与预测（按服务）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲核酸治疗CDMO主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按服务）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲核酸治疗CDMO主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按服务）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 核酸治疗 CDMO 产业

  • 竞争仪表板
  • 公司简介
    • Catalent
    • Thermo Fisher Scientific
    • Lonza
    • FUJIFILM Diosynth Biotechnologies
    • Cognate BioServices
    • Eurofins Genomics
    • Sirion Biotech
    • Oxford Biomedica
    • Danaher (Aldevron)
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2052

REPORT HIGHLIGHT

Nucleic Acid Therapeutics CDMO Market size was valued at USD 11,756.3 Million in 2022, expanding at a CAGR of 10.3% from 2023 to 2030.

Nucleic acid Contract Development and Manufacturing Organizations (CDMOs) hold a critical position in the ever-changing realm of pharmaceutical advancements. Their specialized proficiency in developing, manufacturing, and producing nucleic acid-based therapeutics, such as mRNA, siRNA, gene therapies, and oligonucleotides, underscores their importance in turning innovative research into practical treatments.

Nucleic Acid Therapeutics CDMO Market- Market Dynamics

Advancements in nucleic acid therapeutics, intricate manufacturing procedures, and heightened investments to propel market demand

The market is primarily steered by advancements in nucleic acid therapeutics, intricate manufacturing procedures, and heightened investments. Additionally, the increasing regulatory approvals for nucleic acid therapeutics and the global rise in demand for personalized medicine are poised to drive the need for cost-effective CDMO services, consequently propelling market expansion. Nucleic acid treatments offer personalized healthcare by tailoring to an individual's genetic makeup. With the escalating demand for precision medicine and targeted therapies, these CDMOs emerge as vital partners for pharmaceutical and bioEnd User firms aiming to leverage the potential of nucleic acid-based medications.Their commitment to upholding rigorous quality standards, navigating through regulatory complexities, and employing state-of-the-art technologies facilitates efficient and scalable production of these intricate molecules. Consequently, this drives advancements and accessibility to transformative nucleic acid-based therapies, addressing a wide array of medical necessities.

Nucleic Acid Therapeutics CDMO Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.3% over the forecast period (2023-2030)
  • Based on product type segmentation, RNA-based therapies was predicted to show maximum market share in the year 2022
  • Based on Service segmentation, manufacturing services was the leading type in 2022
  • Based on Application segmentation, Oncology was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Nucleic Acid Therapeutics CDMO Market- Segmentation Analysis:

  • The Global Nucleic Acid Therapeutics CDMO Market is segmented on the basis of Product Type, Service, Application, End User, and Region.
  • The market is divided into two categories based on product type: Gene Therapy and RNA-based Therapies. In 2022, the RNA-based therapies sector emerged as the dominant force in the global market. ClinicalTrials.gov data revealed over 3,500 ongoing clinical trials involving RNA therapies for diverse diseases. Encouraging results from recent trials underscore the substantial potential of RNA-based medications in addressing various illnesses, anticipated to propel the growth of this segment.
  • The market is divided into four categories based on Service: Process Development and Optimization, Manufacturing Services, Analytical and Quality Control Services and Others. The manufacturing services category commanded a significant revenue share in 2022. Nucleic acid-based therapies, encompassing RNA and gene therapies, demand specialized knowledge and expertise in manufacturing. CDMOs exclusively focused on nucleic acid manufacturing have cultivated an in-depth understanding of these therapies, granting them a competitive edge. Within the nucleic acid therapeutics CDMO market, services are further segmented into process development and optimization, manufacturing services, analytical and quality control services, and others.

Nucleic Acid Therapeutics CDMO Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Nucleic Acid Therapeutics CDMO Market- Competitive Landscape:

Within the dynamic sphere of nucleic acid Contract Development and Manufacturing Organizations (CDMOs), companies navigate the industry strategically by adopting multifaceted approaches. These entities prioritize specialization by focusing efforts on mRNA, siRNA, gene editing, or oligonucleotide synthesis segments. By refining expertise in these specialized domains, CDMOs offer customized solutions and optimized services tailored to their clients' specific requirements. Concurrently, they emphasize substantial investments in state-of-the-art End User and infrastructure, ensuring their facilities are equipped with the latest advancements in nucleic acid manufacturing processes. Compliance remains a fundamental aspect of their operations, with stringent attention on meeting and exceeding regulatory standards set by bodies like the FDA or EMA. Moreover, flexibility and scalability are emphasized in their services, enabling adaptable manufacturing solutions accommodating diverse project sizes and specifications. This adaptability facilitates agility in response to the evolving needs of pharmaceutical and bioEnd User partners, consolidating their position in the competitive market.

Recent Developments:

In April 2023, Exothera collaborated with Quantoom Biosciences to leverage Quantoom's innovative Nfinity End User-a cutting-edge continuous production platform crafted for RNA. This partnership positions Exothera as the pioneering Contract Development and Manufacturing Organization (CDMO) globally to offer an off-the-shelf service for continuous RNA production, expanding its expertise in the RNA manufacturing domain.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET KEY PLAYERS

  • Catalent
  • Thermo Fisher Scientific
  • Lonza
  • FUJIFILM Diosynth Biotechnologies
  • Cognate BioServices
  • Eurofins Genomics
  • Sirion Biotech
  • Oxford Biomedica
  • Danaher (Aldevron)
  • Others

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY PRODUCT TYPE

  • Gene Therapy
  • RNA-based Therapies

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY SERVICE

  • Process Development and Optimization
  • Manufacturing Services
  • Analytical and Quality Control Services
  • Others

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY APPLICATION

  • Oncology
  • Genetic Disorders
  • Infectious Diseases
  • Others

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY END USER

  • Pharmaceutical Companies
  • Government & Academic Research Institutes
  • Biotech Companies

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Nucleic Acid Therapeutics CDMO Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Nucleic Acid Therapeutics CDMO Market Snippet by Product Type
    • 2.1.2. Nucleic Acid Therapeutics CDMO Market Snippet by Service
    • 2.1.3. Nucleic Acid Therapeutics CDMO Market Snippet by Application
    • 2.1.4. Nucleic Acid Therapeutics CDMO Market Snippet by End User
    • 2.1.5. Nucleic Acid Therapeutics CDMO Market Snippet by Country
    • 2.1.6. Nucleic Acid Therapeutics CDMO Market Snippet by Region
  • 2.2. Competitive Insights

3. Nucleic Acid Therapeutics CDMO Key Market Trends

  • 3.1. Nucleic Acid Therapeutics CDMO Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Nucleic Acid Therapeutics CDMO Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Nucleic Acid Therapeutics CDMO Market Opportunities
  • 3.4. Nucleic Acid Therapeutics CDMO Market Future Trends

4. Nucleic Acid Therapeutics CDMO Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Nucleic Acid Therapeutics CDMO Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Nucleic Acid Therapeutics CDMO Market Landscape

  • 6.1. Nucleic Acid Therapeutics CDMO Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Nucleic Acid Therapeutics CDMO Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Gene Therapy
    • 7.1.3. RNA-based Therapies

8. Nucleic Acid Therapeutics CDMO Market - By Service

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Service, 2022 & 2030 (%)
    • 8.1.2. Process Development and Optimization
    • 8.1.3. Manufacturing Services
    • 8.1.4. Analytical and Quality Control Services
    • 8.1.5. Others

9. Nucleic Acid Therapeutics CDMO Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 9.1.2. Oncology
    • 9.1.3. Genetic Disorders
    • 9.1.4. Infectious Diseases
    • 9.1.5. Others

10. Nucleic Acid Therapeutics CDMO Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
    • 10.1.2. Pharmaceutical Companies
    • 10.1.3. Government & Academic Research Institutes
    • 10.1.4. Biotech Companies

11. Nucleic Acid Therapeutics CDMO Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Nucleic Acid Therapeutics CDMO Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Catalent
    • 12.2.2. Thermo Fisher Scientific
    • 12.2.3. Lonza
    • 12.2.4. FUJIFILM Diosynth Biotechnologies
    • 12.2.5. Cognate BioServices
    • 12.2.6. Eurofins Genomics
    • 12.2.7. Sirion Biotech
    • 12.2.8. Oxford Biomedica
    • 12.2.9. Danaher (Aldevron)
    • 12.2.10. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Nucleic Acid Therapeutics CDMO Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Nucleic Acid Therapeutics CDMO Market, by Product Type 2018-2030 (USD Million)
  • TABLE Nucleic Acid Therapeutics CDMO Market: Service Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Service
  • TABLE Global Nucleic Acid Therapeutics CDMO Market, by Service 2018-2030 (USD Million)
  • TABLE Nucleic Acid Therapeutics CDMO Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Nucleic Acid Therapeutics CDMO Market, by Application 2018-2030 (USD Million)
  • TABLE Nucleic Acid Therapeutics CDMO Market: End User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Nucleic Acid Therapeutics CDMO Market, by End User 2018-2030 (USD Million)
  • TABLE Nucleic Acid Therapeutics CDMO Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Nucleic Acid Therapeutics CDMO Market, by Region 2018-2030 (USD Million)
  • TABLE North America Nucleic Acid Therapeutics CDMO Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Nucleic Acid Therapeutics CDMO Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Nucleic Acid Therapeutics CDMO Market, by Service, 2018-2030 (USD Million)
  • TABLE North America Nucleic Acid Therapeutics CDMO Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Nucleic Acid Therapeutics CDMO Market, by End User, 2018-2030 (USD Million)
  • TABLE Europe Nucleic Acid Therapeutics CDMO Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Nucleic Acid Therapeutics CDMO Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Nucleic Acid Therapeutics CDMO Market, by Service, 2018-2030 (USD Million)
  • TABLE Europe Nucleic Acid Therapeutics CDMO Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Nucleic Acid Therapeutics CDMO Market, by End User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Nucleic Acid Therapeutics CDMO Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Nucleic Acid Therapeutics CDMO Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Nucleic Acid Therapeutics CDMO Market, by Service, 2018-2030 (USD Million)
  • TABLE Asia Pacific Nucleic Acid Therapeutics CDMO Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Nucleic Acid Therapeutics CDMO Market, by End User, 2018-2030 (USD Million)
  • TABLE Latin America Nucleic Acid Therapeutics CDMO Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Nucleic Acid Therapeutics CDMO Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Nucleic Acid Therapeutics CDMO Market, by Service, 2018-2030 (USD Million)
  • TABLE Latin America Nucleic Acid Therapeutics CDMO Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Nucleic Acid Therapeutics CDMO Market, by End User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Nucleic Acid Therapeutics CDMO Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Nucleic Acid Therapeutics CDMO Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Nucleic Acid Therapeutics CDMO Market, by Service, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Nucleic Acid Therapeutics CDMO Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Nucleic Acid Therapeutics CDMO Market, by End User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Nucleic Acid Therapeutics CDMO Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product Type segment market share analysis, 2022 & 2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Service segment market share analysis, 2022 & 2030
  • FIGURE Service segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End User segment market share analysis, 2022 & 2030
  • FIGURE End User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Nucleic Acid Therapeutics CDMO Market share and leading players, 2022
  • FIGURE Europe Nucleic Acid Therapeutics CDMO Market share and leading players, 2022
  • FIGURE Asia Pacific Nucleic Acid Therapeutics CDMO Market share and leading players, 2022
  • FIGURE Latin America Nucleic Acid Therapeutics CDMO Market share and leading players, 2022
  • FIGURE Middle East and Africa Nucleic Acid Therapeutics CDMO Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Nucleic Acid Therapeutics CDMO Market share analysis by country, 2022
  • FIGURE Germany Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Nucleic Acid Therapeutics CDMO Market share analysis by country, 2022
  • FIGURE India Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Nucleic Acid Therapeutics CDMO Market share analysis by country, 2022
  • FIGURE Brazil Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Nucleic Acid Therapeutics CDMO Market share analysis by country, 2022
  • FIGURE Saudi Arabia Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)